Paul B Manning

Insider Reports History

Location
Charlottesville, VA
Signature
/s/ Mark Ballantyne, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul B Manning:

Company Role Class Num Shares Value Price $ Report Date Ownership
Liquidia Corp Director Common Stock 3,131,794 $87,690,232 $28.00 28 Aug 2025 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3,958,189 $16,792,616 $4.24 25 Nov 2025 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3,348,372 $14,205,468 $4.24 25 Nov 2025 Indirect
Liquidia Corp Director Common Stock 430,828 $12,554,327 $29.14 02 Sep 2025 Indirect
Candel Therapeutics, Inc. Director Common Stock 2,213,069 $10,335,032 $4.67 25 Jun 2025 By Paul B. Manning Revocable Trust
Candel Therapeutics, Inc. Director Common Stock 1,681,000 $8,085,610 $4.81 25 Jun 2025 Direct
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 2,841,704 $7,814,686 $2.75 30 May 2025 Indirect
Candel Therapeutics, Inc. Director Common Stock 1,303,752 $6,271,047 $4.81 25 Jun 2025 By BKB Growth Investments, LLC
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 657,985 $2,283,603 $3.47 06 Jul 2021 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 332,433 $1,173,488 $3.53 25 Nov 2025 By trust
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 9,213,483 22 Nov 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 9,213,483 22 Nov 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 2,247,191 22 Nov 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 2,247,191 22 Nov 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 687,690 25 Nov 2025 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 343,845 25 Nov 2025 Direct
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14,240 17 Jun 2025 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Jul 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 06 Jul 2021 Indirect

Insider Reports Filed by Paul B Manning

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRCA Verrica Pharmaceuticals Inc. 25 Nov 2025 4 +$17,505,157 4 Director, 10%+ Owner 25 Nov 2025, 19:00
LQDA Liquidia Corp 28 Aug 2025 4 -$18,957,475 4 Director 02 Sep 2025, 19:46
CADL Candel Therapeutics, Inc. 25 Jun 2025 1 +$4,999,996 4 Director 26 Jun 2025, 08:30
LQDA Liquidia Corp 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:32
CADL Candel Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 08:35
TSHA Taysha Gene Therapies, Inc. 30 May 2025 1 +$2,062,500 4 10%+ Owner 03 Jun 2025, 21:38
CADL Candel Therapeutics, Inc. 16 Dec 2024 2 +$7,500,000 4 Director 18 Dec 2024, 16:11
VRCA Verrica Pharmaceuticals Inc. 22 Nov 2024 7 $0 4 Director, 10%+ Owner 26 Nov 2024, 16:15
VRCA Verrica Pharmaceuticals Inc. 19 Sep 2024 4 $0 4 Director, 10%+ Owner 23 Sep 2024, 16:15
LQDA Liquidia Corp 12 Sep 2024 1 +$2,999,994 4 Director 16 Sep 2024, 16:05
TSHA Taysha Gene Therapies, Inc. 27 Jun 2024 1 +$2,999,999 4 10%+ Owner 01 Jul 2024, 08:00
CADL Candel Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 08:37
LQDA Liquidia Corp 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 21:39
LQDA Liquidia Corp 14 Dec 2023 1 +$2,000,003 4 Director 18 Dec 2023, 17:00
TSHA Taysha Gene Therapies, Inc. 17 Nov 2023 1 +$163,000 4 10%+ Owner 20 Nov 2023, 07:35
TSHA Taysha Gene Therapies, Inc. 16 Aug 2023 1 +$14,820,000 4 10%+ Owner 16 Aug 2023, 21:57
VRCA Verrica Pharmaceuticals Inc. 24 Jul 2023 1 +$1,004,000 4 Director, 10%+ Owner 24 Jul 2023, 18:47
CADL Candel Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 29 Jun 2023, 09:00
LQDA Liquidia Corp 19 Jun 2023 1 $0 4 Director 21 Jun 2023, 17:01
TSHA Taysha Gene Therapies, Inc. 31 Oct 2022 1 +$3,000,000 4 Director, 10%+ Owner 02 Nov 2022, 16:09
CADL Candel Therapeutics, Inc. 13 Oct 2022 1 $0 4 Director 17 Oct 2022, 16:36
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 +$9,999,998 4 Director, 10%+ Owner 05 Jul 2022, 16:10
TSHA Taysha Gene Therapies, Inc. 17 Jun 2022 1 $0 4 Director, 10%+ Owner 22 Jun 2022, 16:36
LQDA Liquidia Corp 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:31
LQDA Liquidia Corp 18 Apr 2022 1 +$1,999,996 4 Director 19 Apr 2022, 16:30
LQDA Liquidia Corp 31 Mar 2022 1 $0 4 Director 20 Apr 2022, 16:36
TSHA Taysha Gene Therapies, Inc. 02 Feb 2022 5 +$1,571,810 4 Director, 10%+ Owner 04 Feb 2022, 07:28
LQDA Liquidia Corp 31 Dec 2021 0 $0 5/A Director, 10%+ Owner 04 May 2022, 16:51
VRCA Verrica Pharmaceuticals Inc. 31 Dec 2021 2 $0 5 Director, 10%+ Owner 14 Feb 2022, 20:15
CADL Candel Therapeutics, Inc. 31 Dec 2021 1 $0 5 Director, 10%+ Owner 14 Feb 2022, 15:37
VRCA Verrica Pharmaceuticals Inc. 02 Dec 2021 2 +$467,905 4 Director, 10%+ Owner 06 Dec 2021, 07:20
TSHA Taysha Gene Therapies, Inc. 24 Nov 2021 1 +$29,044 4 Director, 10%+ Owner 29 Nov 2021, 16:01
TSHA Taysha Gene Therapies, Inc. 23 Nov 2021 1 +$250,800 4 Director, 10%+ Owner 24 Nov 2021, 06:58
LQDA Liquidia Corp 20 Aug 2021 1 $0 4 Director 01 Sep 2021, 17:24
CADL Candel Therapeutics, Inc. 29 Jul 2021 5 +$13,000,000 4/A Director, 10%+ Owner 04 Aug 2021, 16:41
CADL Candel Therapeutics, Inc. 27 Jul 2021 2 +$410,778 4 Director 29 Jul 2021, 21:02
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Director 26 Jul 2021, 21:24
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 6 +$5,000,000 4 10%+ Owner 08 Jul 2021, 18:35
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 10%+ Owner 30 Jun 2021, 19:11
TSHA Taysha Gene Therapies, Inc. 17 Jun 2021 1 $0 4 Director, 10%+ Owner 21 Jun 2021, 16:59
TSHA Taysha Gene Therapies, Inc. 14 May 2021 1 +$251,760 4 Director, 10%+ Owner 17 May 2021, 07:48